PKB/Akt mediates radiosensitization by the signaling inhibitor LY294002 in human malignant gliomas Jean L. NakamuraAmelia KarlssonDaphne A. Haas-Kogan Laboratory Investigation Pages: 215 - 222
PAX6 suppresses growth of human glioblastoma cells Yi-Hong ZhouXiaosong WuW. K. Alfred Yung Laboratory Investigation Pages: 223 - 229
T cell response to Hu-D peptides in patients with anti-Hu syndrome A. RousseauB. BenyahiaJ. Choppin Laboraatory Investigation Pages: 231 - 236
Cell proliferative activity estimated by histone H2B mRNA level correlates with cytogenetic damage induced by radiation in human glioblastoma cell lines Jerzy SlowinskiUrszula MazurekRyszard Mrowka Laboratory Investigation Pages: 237 - 243
Up-regulation of neuropoiesis generating glial progenitors that infiltrate ratintracranial glioma Christopher DuntschQihong ZhouTayebeh Pourmotabbed OriginalPaper Pages: 245 - 255
Cavernous hemangioma of the thalamus Anna MhoyanRobert FulbrightSergei I. Bannykh Images in Neuro-Oncology Pages: 257 - 257
Double-platinum chemotherapy combined with etoposide in metastatic brain tumor from small cell lung carcinoma Shoko M. YamadaShokei YamadaHitoshi Nakayama Clinical Study Pages: 259 - 265
Stroke as a first manifestation of ovarian cancer Andreas BorowskiAli GhodsizadEmmeran Gams Clinical Study Pages: 267 - 269
Combined chemotherapy and radiotherapy for intracranial germinomas in adultpatients: a single-institution study Antonio SilvaniMarica EoliAmerigo Boiardi Clinical Study Pages: 271 - 276
Gefitinib (‘Iressa’, ZD1839) is active against brain metastases in a 77 year old patient Enrico RoggeroBusi GiancarlaPedrazzini Augusto Clinical Study Pages: 277 - 280
Assessing perfusion changes during whole brain irradiation for patients with cerebral metastases Barbara-Ann M. MillarThomas G. PurdieNormand Laperriere Clinical Study Pages: 281 - 286
Distribution of BPA and metabolic assessment in glioblastoma patients during BNCT treatment: a microdialysis study A. Tommy BergenheimJacek CapalaRoger Henriksson Clinical Study Pages: 287 - 293
UKT-04 trial of continuous metronomic low-dose chemotherapy with methotrexate and cyclophosphamide for recurrent glioblastoma Ulrich HerrlingerJohannes RiegerMichael Weller Clinical Study Pages: 295 - 299
A Phase II trial of paclitaxel and topotecan with filgrastim in patients with recurrent or refractory glioblastoma multiforme or anaplastic astrocytoma J. Marc PipasLouise P. MeyerCamilo E. Fadul Clinical Study Pages: 301 - 305
Gamma Knife radiosurgery for intracranial metastatic melanoma: an analysis of survival and prognostic factors Mehmet KocJohn McGregorReinhard A. Gahbauer Clinical Study Pages: 307 - 313
Treatment-related myelodysplastic syndrome after temozolomide for recurrent high-grade glioma Ying-Wen SuMing-Chih ChangRuey-Kuen Hsieh Clinical Study Pages: 315 - 318
Recurrent low-grade gliomas: the role of fractionated stereotactic re-irradiation S. E. CombsR. AhmadiJ. Debus Clinical Study Pages: 319 - 323
Evaluation of 11C-methionine PET as a surrogate endpoint after treatment of grade 2 gliomas Dan RibomMarjoleine SchoenmaekersAnja Smits Clinical Study Pages: 325 - 332
Successful treatment of a chemoresistant tumor with temozolomide in an adult patient: report of a recurrent intracranial mesenchymal chondrosarcoma Sercan AksoyHuseyin AbalıNilüfer Güler Letter to the Editor Pages: 333 - 334
Chronic inflammatory polyneuropathy revealing malignant melanoma A. RousseauF. SalachasM. Sanson Letter to the Editor Pages: 335 - 336